Income StatementBalance SheetCash FlowSegments
UnitedHealth Group logo

UnitedHealth Group Income Statement

Revenue, expenses, and profitability over time

UnitedHealth Group generated $449.71B in trailing twelve-month revenue, up 0.1% year-over-year. Net income was $12.0B with a 2.68% net margin. Gross margin stands at 88.64% and operating margin at 4.19%. Diluted EPS is $13.25, which declined 0.4% year-over-year. Based on the Q1 2026 filing.

Total Revenue (TTM)$449.71BGross Profit (TTM)$398.63BOperating Income (TTM)$18.8BNet Income (TTM)$12.0BEps Diluted (TTM)$13.25
Latest FilingQ1 2026
Report Date2026-05-05
Market Cap$352.79B
P/E Ratio29.29
ROE11.77%

Earnings Per Share

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Weighted Average Diluted Shares Adjustment—$6.0M$3.0M$2.0M—$2.0M
Basic earnings per share$6.03$6.90$3.76$2.59$0.01$6.92
Diluted earnings per share$5.98$6.85$3.74$2.59$0.02$6.90
Weighted Average Diluted Shares Adjustment—$6.0M$3.0M$2.0M—$2.0M
Antidilutive Securities Excluded from EPS—6M13M16M—18M
Weighted average number diluted shares outstanding adjustment—$6.0M$3.0M$2.0M—$2.0M
Weighted-average shares, basic—912M907M906M—908M
Weighted-average shares, diluted—918M910M908M—910M

Other Income & Expense

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Investment Income, Interest and Dividend$1.6B$1.0B$1.1B$1.1B$647.0M$1.1B
Interest expense$1.0B$998.0M$1.0B$1.0B$974.0M$955.0M

Operating Expenses

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Depreciation and amortization$1.0B$1.1B$1.1B$1.1B$1.1B$1.0B
Loss on sale of subsidiaries$0.0-$15.0M-$41.0M-$83.0M-$126.0M-$72.0M
Selling, general and administrative$12.5B$13.6B$13.8B$15.2B$17.0B$15.4B
Total operating expenses$93.0B$100.5B$106.5B$108.8B$112.8B$102.7B

Operating Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Gross profit$88.3B$97.2B$98.6B$100.6B$100.5B$98.9B
Operating income$7.8B$9.1B$5.2B$4.3B$380.0M$9.0B

Income Before Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income before income taxes$6.8B$8.1B$4.1B$3.2B$0.0$8.0B

Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income tax expense$1.0B$1.6B$510.0M$686.0M—$1.5B

Net Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net income$5.5B$6.3B$3.4B$2.3B$10.0M$6.3B

Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net premiums earned$76.5B$86.5B$87.9B$89.0B$88.8B$87.6B
Investment and other income$1.6B$1.0B$1.1B$1.1B$647.0M$1.1B
Total revenue$100.8B$109.6B$111.6B$113.2B$113.2B$111.7B
Investment and other income$1.6B$1.0B$1.1B$1.1B$647.0M$1.1B

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Stock options excluded as their inclusion would be anti-dilutive (in shares)—$6.0M$13.0M$16.0M—$18.0M
Loss on sale of subsidiary and subsidiaries held for sale$0.0-$15.0M-$41.0M-$83.0M-$126.0M-$72.0M
Add: dilutive effect of potential common shares (in shares)—$6.0M$3.0M$2.0M—$2.0M

Cost of Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total cost of revenue$12.5B$12.4B$13.0B$12.6B$12.7B$12.8B
Medical costs$67.0B$73.4B$78.6B$80.0B$82.0B$73.5B